Whittier Trust’s Halozyme HALO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$21.8K Hold
270
﹤0.01% 1012
2026
Q1
$17K Hold
270
﹤0.01% 1029
2025
Q4
$19.7K Hold
270
﹤0.01% 1029
2025
Q3
$18.6K Hold
270
﹤0.01% 1013
2025
Q2
$14K Hold
270
﹤0.01% 1171
2025
Q1
$17.2K Hold
270
﹤0.01% 1129
2024
Q4
$12.9K Hold
270
﹤0.01% 1204
2024
Q3
$15.5K Hold
270
﹤0.01% 1174
2024
Q2
$14.1K Sell
270
-402
-60% -$17.6K ﹤0.01% 1183
2024
Q1
$27.3K Buy
+672
New +$25.2K ﹤0.01% 1058
2022
Q2
Sell
-41
Closed -$2K 1715
2022
Q1
$2K Buy
+41
New +$1.46K ﹤0.01% 1580

Other funds holding HALO

Whittier Trust's HALO Position: Q2 2026 in Review

Whittier Trust held its Halozyme (HALO) position steady in Q2 2026 at 270 shares worth $21.8K. The position accounts for ﹤0.01% of the portfolio, ranked #1012.

Whittier Trust first reported a position in HALO in Q1 2022 and has held it in 11 quarters since. The position peaked at $27.3K in Q1 2024. 671 funds tracked by Wall St. Rank hold HALO as of Q2 2026.

  • Whittier Trust held 270 shares of Halozyme worth $21.8K as of Q2 2026.
  • Whittier Trust left its Halozyme share count unchanged in Q2 2026.
  • Halozyme made up ﹤0.01% of Whittier Trust's portfolio in Q2 2026, its #1012 holding.
  • Whittier Trust first reported a position in Halozyme in Q1 2022 and has held it in 11 quarters since.
  • Whittier Trust's Halozyme position peaked at $27.3K in Q1 2024.
  • 671 funds tracked by Wall St. Rank held Halozyme as of Q2 2026.

Based on Whittier Trust's 13F filing for Q2 2026, filed 28 Jul 2026.